Betalife

BetaLife is a stem cell therapy company, spun out of the Institute of Molecular and Cell Biology (IMCB), A*STAR in Singapore, that is focused on regenerative medicine for diabetes. We are backed by a founding team with more than a decade of experience in stem cells and diabetes. We generate research-grade human induced pluripotent stem cell (hiPSCs) products, as well as high quality, clinical-grade hiPSCs that can be developed into pancreatic beta cells for cell replacement therapy. We also conduct personalised cell/hiPSC banking to safeguard your future. We are passionate about the science, but more importantly our mission is to use cell therapy products to make a difference to the lives of diabetes patients and others.